{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:05:42Z","timestamp":1794557142014,"version":"4.9.1"},"reference-count":74,"publisher":"Bentham Science Publishers Ltd.","issue":"24","funder":[{"DOI":"10.13039\/501100006319","name":"CNRST, Centre National pour la Recherche Scientifique et Technique","doi-asserted-by":"publisher","award":["PPR\/2015\/35"],"award-info":[{"award-number":["PPR\/2015\/35"]}],"id":[{"id":"10.13039\/501100006319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,9,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The pathophysiology of hypertension is often associated with endothelial dysfunction and the impairment\nof endothelium-dependent vasodilation mechanisms, as well as alterations in vascular smooth muscle (VSM)\ntone. Natural products, particularly alkaloids, have received increased attention in the search for new vasodilator\nagents. This review aims to summarize the noteworthy results from ex-vivo and in-vitro studies that explored\nthe vasodilatory effects of some selected alkaloids (Berberine, Sinomenine, (S)-Reticuline, Neferine, Nuciferine,\nVillocarine A, 8-Oxo-9-Dihydromakonakine, Harmaline, Harman, and Capsaicin) and the underlying\nmechanisms implicated. The results obtained from the literature revealed that these selected alkaloids exhibited\nvasodilation in various vascular models, including mesenteric, carotid, and coronary arteries, thoracic aorta,\nand cultured HUCECs and VSMCs. Furthermore, most of these alkaloids induced vasodilation through endothelium-\ndependent and endothelium-independent mechanisms, which were primarily mediated by activating\neNOS\/NO\/sGC\/cGMP pathway, opening various potassium (K+) channels, or modulating calcium (Ca2+) channels.\nAdditionally, several alkaloids exerted vasodilatory effects through multiple mechanism pathways. Moreover,\ndifferent alkaloids demonstrated the ability to protect endothelial function by reducing oxidative stress, endoplasmic\nreticulum and inflammation. In conclusion, this class of secondary metabolites holds interesting therapeutic\npotential in the prevention and treatment of cardiovascular diseases (CVD), particularly hypertension.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666230809094313","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T04:33:16Z","timestamp":1691641996000},"page":"1886-1895","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Alkaloids as Vasodilator Agents: A Review"],"prefix":"10.2174","volume":"29","author":[{"given":"Ayoub","family":"Amssayef","sequence":"first","affiliation":[{"name":"Team of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of\nMeknes, BP 509, Boutalamine, Errachidia, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eddouks","sequence":"additional","affiliation":[{"name":"Team of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of\nMeknes, BP 509, Boutalamine, Errachidia, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"Mills K.T.","year":"2020","unstructured":"Mills K.T.; Stefanescu A.; He J.; The global epidemiology of hypertension. Nat Rev Nephrol 2020,16(4),223-237","journal-title":"Nat Rev Nephrol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"Fuchs F.D.","year":"2020","unstructured":"Fuchs F.D.; Whelton P.K.; High blood pressure and cardiovascular disease. Hypertension 2020,75(2),285-292","journal-title":"Hypertension"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.3390\/ijms22147284","volume":"22","author":"M\u00e9ndez-Barbero N.","year":"2021","unstructured":"M\u00e9ndez-Barbero N.; Guti\u00e9rrez-Mu\u00f1oz C.; Blanco-Colio L.; Cellular crosstalk between endothelial and smooth muscle cells in vascular wall remodeling. Int J Mol Sci 2021,22(14),7284","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1161\/HYPERTENSIONAHA.119.13791","volume":"74","author":"Wilson C.","year":"2019","unstructured":"Wilson C.; Zhang X.; Buckley C.; Heathcote H.R.; Lee M.D.; McCarron J.G.; Increased vascular contractility in hypertension results from impaired endothelial calcium signaling. Hypertension 2019,74(5),1200-1214","journal-title":"Hypertension"},{"key":"ref=5","first-page":"424","volume":"129","author":"Zsot\u00e9r T.T.","year":"1983","unstructured":"Zsot\u00e9r T.T.; Vasodilators. Can Med Assoc J 1983,129(5),424-428, 432","journal-title":"Can Med Assoc J"},{"key":"ref=6","author":"Hariri L.","year":"2023","unstructured":"Hariri L.; Patel J.B.;  StatPearls 2023","journal-title":"StatPearls"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/bcpt.13377","volume":"127","author":"Shimokawa H.","year":"2020","unstructured":"Shimokawa H.; Godo S.; Nitric oxide and endothelium-dependent hyperpolarization mediated by hydrogen peroxide in health and disease. Basic Clin Pharmacol Toxicol 2020,127(2),92-101","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Zhao Y.","year":"2015","unstructured":"Zhao Y.; Vanhoutte P.M.; Leung S.W.S.; Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci 2015,129(2),83-94","journal-title":"J Pharmacol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/ijms19061712","volume":"19","author":"Krishnan S.","year":"2018","unstructured":"Krishnan S.; Kraehling J.; Eitner F.; B\u00e9nardeau A.; Sandner P.; The impact of the nitric oxide (NO)\/soluble guanylyl cyclase (sGC) signaling cascade on kidney health and disease: A preclinical perspective. Int J Mol Sci 2018,19(6),1712","journal-title":"Int J Mol Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jep.2009.09.057","volume":"127","author":"Ameer O.Z.","year":"2010","unstructured":"Ameer O.Z.; Salman I.M.; Siddiqui M.J.A.; Yam M.F.; Sriramaneni R.N.; Mohamed A.J.; Sadikun A.; Ismail Z.; Shah A.M.; Asmawi M.Z.; Pharmacological mechanisms underlying the vascular activities of Loranthus ferrugineus Roxb. in rat thoracic aorta. J Ethnopharmacol 2010,127(1),19-25","journal-title":"J Ethnopharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1568016043356273","volume":"2","author":"Tanaka Y.","year":"2004","unstructured":"Tanaka Y.; Yamaki F.; Koike K.; Toro L.; New insights into the intracellular mechanisms by which PGI2 analogues elicit vascular relaxation: Cyclic AMP-independent, Gs-protein mediated-activation of MaxiK channel. Curr Med Chem Cardiovasc Hematol Agents 2004,2(3),257-265","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.bjp.0703301","volume":"130","author":"Walch L.","year":"2000","unstructured":"Walch L.; Gascard J.P.; Dulmet E.; Brink C.; Norel X.; Evidence for a M muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol 2000,130(1),73-78","journal-title":"Br J Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/japplphysiol.00728.2004","volume":"98","author":"Kellogg D.L.","year":"2005","unstructured":"Kellogg D.L.; Zhao J.L.; Coey U.; Green J.V.; Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 2005,98(2),629-632","journal-title":"J Appl Physiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJM198610233151702","volume":"315","author":"Ludmer P.L.","year":"1986","unstructured":"Ludmer P.L.; Selwyn A.P.; Shook T.L.; Wayne R.R.; Mudge G.H.; Alexander R.W.; Ganz P.; Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986,315(17),1046-1051","journal-title":"N Engl J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1111\/febs.15863","volume":"288","author":"Rodr\u00edguez C.","year":"2021","unstructured":"Rodr\u00edguez C.; Mu\u00f1oz M.; Contreras C.; Prieto D.; AMPK, metabolism, and vascular function. FEBS J 2021,288(12),3746-3771","journal-title":"FEBS J"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fphys.2018.01249","volume":"9","author":"Kee Z.","year":"2018","unstructured":"Kee Z.; Kodji X.; Brain S.D.; The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects. Front Physiol 2018,9,1249","journal-title":"Front Physiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"Russell F.A.","year":"2014","unstructured":"Russell F.A.; King R.; Smillie S.J.; Kodji X.; Brain S.D.; Calcitonin gene-related peptide: Physiology and pathophysiology. Physiol Rev 2014,94(4),1099-1142","journal-title":"Physiol Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"170121","DOI":"10.1016\/j.peptides.2019.170121","volume":"121","author":"Guo Y.","year":"2019","unstructured":"Guo Y.; Zhang Q.; Chen H.; Jiang Y.; Gong P.; The protective role of calcitonin gene-related peptide (CGRP) in high-glucose-induced oxidative injury in rat aorta endothelial cells. Peptides 2019,121,170121","journal-title":"Peptides"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3892\/ijmm.2016.2779","volume":"38","author":"Dobovi\u0161ek L.","year":"2016","unstructured":"Dobovi\u0161ek L.; Hojnik M.; Ferk P.; Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens\/androgens on the periphery and their involvement in the pathogenesis of common diseases (review). Int J Mol Med 2016,38(6),1642-1651","journal-title":"Int J Mol Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1042\/bj3460835","volume":"346","author":"Liu J.","year":"2000","unstructured":"Liu J.; Gao B.; Mirshahi F.; Sanyal A.J.; Khanolkar A.D.; Makriyannis A.; Kunos G.; Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 2000,346(3),835-840","journal-title":"Biochem J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.pharep.2017.06.011","volume":"69","author":"L\u00f3pez-Dyck E.","year":"2017","unstructured":"L\u00f3pez-Dyck E.; Andrade-Urz\u00faa F.; Elizalde A.; Ferrer-Villada T.; Dagnino-Acosta A.; Huerta M.; Osuna-Calleros Z.; Rangel-Sandoval C.; S\u00e1nchez-Pastor E.; ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK channels, and nitric oxide dependent mechanisms. Pharmacol Rep 2017,69(6),1131-1139","journal-title":"Pharmacol Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejphar.2014.02.016","volume":"729","author":"S\u00e1nchez-Pastor E.","year":"2014","unstructured":"S\u00e1nchez-Pastor E.; Andrade F.; S\u00e1nchez-Pastor J.M.; Elizalde A.; Huerta M.; Virgen-Ortiz A.; Trujillo X.; Rodr\u00edguez-Hern\u00e1ndez A.; Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit. Eur J Pharmacol 2014,729,100-106","journal-title":"Eur J Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10739680590896072","volume":"12","author":"Jackson W.F.","year":"2005","unstructured":"Jackson W.F.; Potassium channels in the peripheral microcirculation. Microcirculation 2005,12(1),113-127","journal-title":"Microcirculation"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1124\/pr.115.010652","volume":"68","author":"Brozovich F.V.","year":"2016","unstructured":"Brozovich F.V.; Nicholson C.J.; Degen C.V.; Gao Y.Z.; Aggarwal M.; Morgan K.G.; Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol Rev 2016,68(2),476-532","journal-title":"Pharmacol Rev"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1933719113504468","volume":"21","author":"Mart\u00edn P.","year":"2014","unstructured":"Mart\u00edn P.; Rebolledo A.; Palomo A.R.R.; Moncada M.; Piccinini L.; Milesi V.; Diversity of potassium channels in human umbilical artery smooth muscle cells: A review of their roles in human umbilical artery contraction. Reprod Sci 2014,21(4),432-441","journal-title":"Reprod Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1124\/pr.58.3.5","volume":"58","author":"Bender A.T.","year":"2006","unstructured":"Bender A.T.; Beavo J.A.; Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol Rev 2006,58(3),488-520","journal-title":"Pharmacol Rev"},{"key":"ref=27","first-page":"1059","author":"Graham R.M.","year":"1986","unstructured":"Graham R.M.; Lanier S.M.;  The Heart and Cardiovascular System 1986,1059-1096","journal-title":"The Heart and Cardiovascular System"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"652152","DOI":"10.3389\/fcell.2021.652152","volume":"9","author":"Perez D.M.","year":"2021","unstructured":"Perez D.M.; Current developments on the role of \u03b11-adrenergic receptors in cognition, cardioprotection, and metabolism. Front Cell Dev Biol 2021,9,652152","journal-title":"Front Cell Dev Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"627458","DOI":"10.3389\/fphar.2021.627458","volume":"12","author":"Tang F.","year":"2021","unstructured":"Tang F.; Yan H.L.; Wang L.X.; Xu J.F.; Peng C.; Ao H.; Tan Y.Z.; Review of natural resources with vasodilation: Traditional medicinal plants, natural products, and their mechanism and clinical efficacy. Front Pharmacol 2021,12,627458","journal-title":"Front Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1097\/00005344-200109011-00004","volume":"37","author":"Enseleit F.","year":"2001","unstructured":"Enseleit F.; H\u00fcrlimann D.; L\u00fcscher T.F.; Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J Cardiovasc Pharmacol 2001,37(Suppl. 1),S21-S30","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"600132","DOI":"10.3389\/fphar.2020.600132","volume":"11","author":"Sim\u00f5es S.C.","year":"2020","unstructured":"Sim\u00f5es S.C.; Balico-Silva A.L.; Parreiras-e-Silva L.T.; Bitencourt A.L.B.; Bouvier M.; Costa-Neto C.M.; Signal transduction profiling of angiotensin II type 1 receptor with mutations associated to atrial fibrillation in humans. Front Pharmacol 2020,11,600132","journal-title":"Front Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/hr.2009.184","volume":"33","author":"Hanif K.","year":"2010","unstructured":"Hanif K.; Bid H.K.; Konwar R.; Reinventing the ACE inhibitors: Some old and new implications of ACE inhibition. Hypertens Res 2010,33(1),11-21","journal-title":"Hypertens Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.3390\/molecules18055814","volume":"18","author":"Luna-V\u00e1zquez F.","year":"2013","unstructured":"Luna-V\u00e1zquez F.; Ibarra-Alvarado C.; Rojas-Molina A.; Rojas-Molina I.; Zavala-S\u00e1nchez M.; Vasodilator compounds derived from plants and their mechanisms of action. Molecules 2013,18(5),5814-5857","journal-title":"Molecules"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.apha.2016.08.002","volume":"78","author":"Ghosh D.","year":"2017","unstructured":"Ghosh D.; Syed A.U.; Prada M.P.; Nystoriak M.A.; Santana L.F.; Nieves-Cintr\u00f3n M.; Navedo M.F.; Calcium channels in vascular smooth muscle. Adv Pharmacol 2017,78,49-87","journal-title":"Adv Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vph.2006.05.004","volume":"45","author":"Cao Y.X.","year":"2006","unstructured":"Cao Y.X.; Zhang W.; He J.Y.; He L.C.; Xu C.B.; Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca influx and release. Vascul Pharmacol 2006,45(3),171-176","journal-title":"Vascul Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1152\/physrev.00026.2014","volume":"95","author":"Earley S.","year":"2015","unstructured":"Earley S.; Brayden J.E.; Transient receptor potential channels in the vasculature. Physiol Rev 2015,95(2),645-690","journal-title":"Physiol Rev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejphar.2014.11.010","volume":"746","author":"Randhawa P.K.","year":"2015","unstructured":"Randhawa P.K.; Jaggi A.S.; TRPV1 and TRPV4 channels: Potential therapeutic targets for ischemic conditioning-induced cardioprotection. Eur J Pharmacol 2015,746,180-185","journal-title":"Eur J Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"677661","DOI":"10.3389\/fmolb.2021.677661","volume":"8","author":"Liu L.","year":"2021","unstructured":"Liu L.; Guo M.; Lv X.; Wang Z.; Yang J.; Li Y.; Yu F.; Wen X.; Feng L.; Zhou T.; Role of transient receptor potential vanilloid 4 in vascular function. Front Mol Biosci 2021,8,677661","journal-title":"Front Mol Biosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/ani9090623","volume":"9","author":"Knox M.","year":"2019","unstructured":"Knox M.; Vinet R.; Fuentes L.; Morales B.; Mart\u00ednez J.L.; A review of endothelium-dependent and-independent vasodilation induced by phytochemicals in isolated rat aorta. Animals (Basel) 2019,9(9),623","journal-title":"Animals (Basel)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4196\/kjpp.2020.24.4.287","volume":"24","author":"Hong K.S.","year":"2020","unstructured":"Hong K.S.; Lee M.G.; Endothelial Ca signaling-dependent vasodilation through transient receptor potential channels. Korean J Physiol Pharmacol 2020,24(4),287-298","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3390\/molecules26113374","volume":"26","author":"Bhambhani S.","year":"2021","unstructured":"Bhambhani S.; Kondhare K.R.; Giri A.P.; Diversity in chemical structures and biological properties of plant alkaloids. Molecules 2021,26(11),3374","journal-title":"Molecules"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5772\/intechopen.102222","author":"Bruce S.O.","year":"2022","unstructured":"Bruce S.O.;  Secondary Metabolites: Trends and Reviews 2022,51","journal-title":"Secondary Metabolites: Trends and Reviews"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-6728-7_2-1","author":"Matsuura HN","year":"2015","unstructured":"Matsuura HN; Fett-Neto AG;  Plant Toxins 2015,1-15","journal-title":"Plant Toxins"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1201\/EBK1420077698","author":"Buckingham J.","year":"2010","unstructured":"Buckingham J.; Baggaley K.H.; Roberts A.D.; Szabo L.F.;  Dictionary of alkaloids, with CD-ROM 2010","journal-title":"Dictionary of alkaloids, with CD-ROM"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-981-15-2361-8_5","author":"Guti\u00e9rrez-Grijalva E.P.","year":"2020","unstructured":"Guti\u00e9rrez-Grijalva E.P.; L\u00f3pez-Mart\u00ednez L.X.; Contreras-Angulo L.A.; Elizalde-Romero C.A.; Heredia J.B.;  Plant-derived Bioactives: Chemistry and Mode of Action 2020,85-117","journal-title":"Plant-derived Bioactives: Chemistry and Mode of Action"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.7150\/ijbs.23247","volume":"14","author":"Hussain G.","year":"2018","unstructured":"Hussain G.; Rasul A.; Anwar H.; Aziz N.; Razzaq A.; Wei W.; Ali M.; Li J.; Li X.; Role of plant derived alkaloids and their mechanism in neurodegenerative disorders. Int J Biol Sci 2018,14(3),341-357","journal-title":"Int J Biol Sci"},{"key":"ref=47","author":"Aniszewski T.","year":"2015","unstructured":"Aniszewski T.;  Alkaloids: Chemistry, biology, ecology, and applications 2015","journal-title":"Alkaloids: Chemistry, biology, ecology, and applications"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11101-019-09648-6","volume":"18","author":"Kumar A.","year":"2019","unstructured":"Kumar A.; Aswal S.; Semwal R.B.; Chauhan A.; Joshi S.K.; Semwal D.K.; Role of plant-derived alkaloids against diabetes and diabetes-related complications: A mechanism-based approach. Phytochem Rev 2019,18(5),1277-1298","journal-title":"Phytochem Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"Feng X.","year":"2019","unstructured":"Feng X.; Sureda A.; Jafari S.; Memariani Z.; Tewari D.; Annunziata G.; Barrea L.; Hassan S.T.S.; \u0160mejkal K.; Malan\u00edk M.; Sychrov\u00e1 A.; Barreca D.; Ziberna L.; Mahomoodally M.F.; Zengin G.; Xu S.; Nabavi S.M.; Shen A.Z.; Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics 2019,9(7),1923-1951","journal-title":"Theranostics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"762654","DOI":"10.3389\/fphar.2021.762654","volume":"12","author":"Ai X.","year":"2021","unstructured":"Ai X.; Yu P.; Peng L.; Luo L.; Liu J.; Li S.; Lai X.; Luan F.; Meng X.; Berberine: A review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Front Pharmacol 2021,12,762654","journal-title":"Front Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0014-2999(00)00339-3","volume":"399","author":"Ko W.H.","year":"2000","unstructured":"Ko W.H.; Yao X.Q.; Lau C.W.; Law W.I.; Chen Z.Y.; Kwok W.; Ho K.; Huang Y.; Vasorelaxant and antiproliferative effects of berberine. Eur J Pharmacol 2000,399(2-3),187-196","journal-title":"Eur J Pharmacol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1537-1891(03)00005-3","volume":"39","author":"Kang D.G.","year":"2002","unstructured":"Kang D.G.; Sohn E.J.; Kwon E.K.; Han J.H.; Oh H.; Lee H.S.; Effects of berberine on angiotensin-converting enzyme and NO\/cGMP system in vessels. Vascul Pharmacol 2002,39(6),281-286","journal-title":"Vascul Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1111\/jcmm.12645","volume":"19","author":"Wang J.","year":"2015","unstructured":"Wang J.; Guo T.; Peng Q.S.; Yue S.W.; Wang S.X.; Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice. J Cell Mol Med 2015,19(11),2607-2616","journal-title":"J Cell Mol Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.bbrc.2015.02.028","volume":"458","author":"Liu L.","year":"2015","unstructured":"Liu L.; Liu J.; Huang Z.; Yu X.; Zhang X.; Dou D.; Huang Y.; Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats. Biochem Biophys Res Commun 2015,458(4),796-801","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/bph.13466","volume":"173","author":"Geng F.H.","year":"2016","unstructured":"Geng F.H.; Li G.H.; Zhang X.; Zhang P.; Dong M.Q.; Zhao Z.J.; Zhang Y.; Dong L.; Gao F.; Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor- mediated signalling in diabetic rats. Br J Pharmacol 2016,173(10),1569-1579","journal-title":"Br J Pharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvp078","volume":"82","author":"Wang Y.","year":"2009","unstructured":"Wang Y.; Huang Y.; Lam K.S.L.; Li Y.; Wong W.T.; Ye H.; Lau C.W.; Vanhoutte P.M.; Xu A.; Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 2009,82(3),484-492","journal-title":"Cardiovasc Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1440-1681.2007.04668.x","volume":"34","author":"Lee P.Y.","year":"2007","unstructured":"Lee P.Y.; Chen W.; Liu I.M.; Cheng J.T.; Vasodilatation induced by sinomenine lowers blood pressure in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2007,34(10),979-984","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-2006-959606","volume":"59","author":"Martin M.","year":"1993","unstructured":"Martin M.; Diaz M.; Montero M.; Prieto P.; Roman L.; Cortes D.; Antispasmodic activity of benzylisoquinoline alkaloids analogous to papaverine. Planta Med 1993,59(1),63-67","journal-title":"Planta Med"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-2004-818944","volume":"70","author":"Dias K.L.","year":"2004","unstructured":"Dias K.L.; Da Silva Dias C.; Barbosa-Filho J.M.; Almeida R.N.; De Azevedo Correia N.; Medeiros I.A.; Cardiovascular effects induced by reticuline in normotensive rats. Planta Med 2004,70(4),328-333","journal-title":"Planta Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00210-008-0352-1","volume":"379","author":"Medeiros M.A.A.","year":"2009","unstructured":"Medeiros M.A.A.; Nunes X.P.; Barbosa-Filho J.M.; Lemos V.S.; Pinho J.F.; Roman-Campos D.; de Medeiros I.A.; Ara\u00fajo D.A.M.; Cruz J.S.; (S)-reticuline induces vasorelaxation through the blockade of L-type Ca channels. Naunyn Schmiedebergs Arch Pharmacol 2009,379(2),115-125","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1055\/a-1123-7852","volume":"86","author":"Wicha P.","year":"2020","unstructured":"Wicha P.; Onsa-ard A.; Chaichompoo W.; Suksamrarn A.; Tocharus C.; Vasorelaxant and antihypertensive effects of neferine in rats: An in vitro and in vivo study. Planta Med 2020,86(7),496-504","journal-title":"Planta Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1111\/bph.13021","volume":"172","author":"Wang X.","year":"2015","unstructured":"Wang X.; Cheang W.S.; Yang H.; Xiao L.; Lai B.; Zhang M.; Ni J.; Luo Z.; Zhang Z.; Huang Y.; Wang N.; Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms. Br J Pharmacol 2015,172(23),5609-5618","journal-title":"Br J Pharmacol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"946445","DOI":"10.3389\/fphar.2022.946445","volume":"13","author":"Deng H.","year":"2022","unstructured":"Deng H.; Xu Q.; Sang X.T.; Huang X.; Jin L.L.; Chen F.E.; Shen Q.K.; Quan Z.S.; Cao L.H.; Study on the vasodilatory activity of lotus leaf extract and its representative substance nuciferine on thoracic aorta in rats. Front Pharmacol 2022,13,946445","journal-title":"Front Pharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1016\/j.bmc.2011.05.014","volume":"19","author":"Matsuo H.","year":"2011","unstructured":"Matsuo H.; Okamoto R.; Zaima K.; Hirasawa Y.; Ismail I.S.; Lajis N.H.; Morita H.; New vasorelaxant indole alkaloids, villocarines A-D from Uncaria villosa. Bioorg Med Chem 2011,19(13),4075-4079","journal-title":"Bioorg Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.3390\/molecules23113050","volume":"23","author":"Cifuentes F.","year":"2018","unstructured":"Cifuentes F.; Palacios J.; Paredes A.; Nwokocha C.; Paz C.; 8-oxo-9-dihydromakomakine isolated from Aristoteliachilensis induces vasodilation in rat aorta: Role of the extracellular calcium influx. Molecules 2018,23(11),3050","journal-title":"Molecules"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.phrs.2006.04.001","volume":"54","author":"Berrougui H.","year":"2006","unstructured":"Berrougui H.; Mart\u00edncordero C.; Khalil A.; Hmamouchi M.; Ettaib A.; Marhuenda E.; Herrera M.; Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seed\u2019s in isolated rat aorta. Pharmacol Res 2006,54(2),150-157","journal-title":"Pharmacol Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0014-2999(99)00928-0","volume":"390","author":"Shi C.C.","year":"2000","unstructured":"Shi C.C.; Chen S.Y.; Wang G.J.; Liao J.F.; Chen C.F.; Vasorelaxant effect of harman. Eur J Pharmacol 2000,390(3),319-325","journal-title":"Eur J Pharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/nu10050630","volume":"10","author":"Panchal S.","year":"2018","unstructured":"Panchal S.; Bliss E.; Brown L.; Capsaicin in metabolic syndrome. Nutrients 2018,10(5),630","journal-title":"Nutrients"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2010.05.015","volume":"12","author":"Yang D.","year":"2010","unstructured":"Yang D.; Luo Z.; Ma S.; Wong W.T.; Ma L.; Zhong J.; He H.; Zhao Z.; Cao T.; Yan Z.; Liu D.; Arendshorst W.J.; Huang Y.; Tepel M.; Zhu Z.; Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 2010,12(2),130-141","journal-title":"Cell Metab"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/1043-6618(94)80107-X","volume":"30","author":"Potenza M.","year":"1994","unstructured":"Potenza M.; De Salvatore G.; Montagnani M.; Serio M.; Mitolo-Chieppa D.; Vasodilatation induced by capsaicin in rat mesenteric vessels is probably independent of nitric oxide synthesis. Pharmacol Res 1994,30(3),253-261","journal-title":"Pharmacol Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00210-007-0137-y","volume":"375","author":"Gupta S.","year":"2007","unstructured":"Gupta S.; Lozano-Cuenca J.; Villal\u00f3n C.M.; de Vries R.; Garrelds I.M.; Avezaat C.J.J.; van Kats J.P.; Saxena P.R.; MaassenVanDenBrink A.; Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries. Naunyn Schmiedebergs Arch Pharmacol 2007,375(1),29-38","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.3390\/molecules25173957","volume":"25","author":"Andrade F.","year":"2020","unstructured":"Andrade F.; Rangel-Sandoval C.; Rodr\u00edguez-Hern\u00e1ndez A.; L\u00f3pez-Dyck E.; Elizalde A.; Virgen-Ortiz A.; Bonales-Alatorre E.; Valencia-Cruz G.; S\u00e1nchez-Pastor E.; Capsaicin causes vasorelaxation of rat aorta through blocking of L-type Ca channels and activation of CB1 receptors. Molecules 2020,25(17),3957","journal-title":"Molecules"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejphar.2012.02.019","volume":"681","author":"Hopps J.J.","year":"2012","unstructured":"Hopps J.J.; Dunn W.R.; Randall M.D.; Vasorelaxation to capsaicin and its effects on calcium influx in arteries. Eur J Pharmacol 2012,681(1-3),88-93","journal-title":"Eur J Pharmacol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1292\/jvms.63.499","volume":"63","author":"Yeon D.","year":"2001","unstructured":"Yeon D.; Kwon S.; Lee Y.; Leem J.; Nam T.; Ahn D.; Capsaicin-induced relaxation in rabbit coronary artery. J Vet Med Sci 2001,63(5),499-503","journal-title":"J Vet Med Sci"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230809094313","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219556\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230809094313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:48:55Z","timestamp":1696596535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219556\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":74,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,9,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666230809094313","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}